Circassia Group Plc (82C) - Total Assets
Based on the latest financial reports, Circassia Group Plc (82C) holds total assets worth €76.20 Million EUR as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Circassia Group Plc - Total Assets Trend (2015–2025)
This chart illustrates how Circassia Group Plc's total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Circassia Group Plc - Asset Composition Analysis
Current Asset Composition (December 2025)
Circassia Group Plc's total assets of €76.20 Million consist of 40.6% current assets and 59.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 26.1% |
| Accounts Receivable | €4.40 Million | 5.8% |
| Inventory | €5.00 Million | 6.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €23.80 Million | 31.2% |
| Goodwill | €4.80 Million | 6.3% |
Asset Composition Trend (2015–2025)
This chart illustrates how Circassia Group Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Circassia Group Plc's current assets represent 40.6% of total assets in 2025, a decrease from 45.7% in 2015.
- Cash Position: Cash and equivalents constituted 26.1% of total assets in 2025, down from 33.9% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, a decrease from 49.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 31.2% of total assets.
Circassia Group Plc Competitors by Total Assets
Key competitors of Circassia Group Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
PolarCool AB (publ)
F:98H0
|
Germany | €10.79 Million |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
Circassia Group Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.81 | 2.60 | 1.11 |
| Quick Ratio | 3.20 | 2.11 | 0.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €22.80 Million | €13.00 Million | €3.00 Million |
Circassia Group Plc - Advanced Valuation Insights
This section examines the relationship between Circassia Group Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.26 |
| Latest Market Cap to Assets Ratio | 3.58 |
| Asset Growth Rate (YoY) | 11.4% |
| Total Assets | €76.20 Million |
| Market Capitalization | $272.60 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Circassia Group Plc's assets at a significant premium (3.58x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Circassia Group Plc's assets grew by 11.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Circassia Group Plc (2015–2025)
The table below shows the annual total assets of Circassia Group Plc from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €76.20 Million | +11.40% |
| 2024-12-31 | €68.40 Million | -25.25% |
| 2023-12-31 | €91.50 Million | -7.11% |
| 2022-12-31 | €98.50 Million | +14.00% |
| 2021-12-31 | €86.40 Million | -16.20% |
| 2020-12-31 | €103.10 Million | -58.23% |
| 2019-12-31 | €246.80 Million | -19.71% |
| 2018-12-31 | €307.40 Million | -23.61% |
| 2017-12-31 | €402.40 Million | +20.44% |
| 2016-12-31 | €334.10 Million | -31.70% |
| 2015-12-31 | €489.20 Million | -- |
About Circassia Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more